Linagliptin/Metformin Hcl
Brand name: Jentadueto
Rank #388 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$24.3M
Total Cost
33,018
Total Claims
$24.3M
Total Cost
1,406
Prescribers
$737
Cost per Claim
1,914
Beneficiaries
47,150
30-Day Fills
$17K
Avg Cost/Provider
23
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$24.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $24.3M total
🔎 Data Overview
Average cost of $12,712 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Linagliptin/Metformin Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Enrique Griego | Family Practice | Mcallen, TX | 185 | $255K |
| 2 | Naomi Collazo Gutierrez | Endocrinology | Manati, PR | 337 | $218K |
| 3 | Matin Sharafatkhah | Endocrinology | Brooklyn, NY | 288 | $195K |
| 4 | Rafael Rodriguez | Internal Medicine | Jackson Heights, NY | 112 | $181K |
| 5 | Baltazar Rodriguez Cruz | General Practice | Lares, PR | 168 | $173K |
| 6 | Alejandra Santiago | Endocrinology | Ponce, PR | 282 | $171K |
| 7 | Samayra Miranda Rodriguez | Endocrinology | Dorado, PR | 238 | $170K |
| 8 | Luis Torres | General Practice | Ponce, PR | 107 | $145K |
| 9 | Yadiel Rivera-Nieves | Internal Medicine | Mayaguez, PR | 218 | $119K |
| 10 | Jung Bae | Internal Medicine | Los Angeles, CA | 143 | $116K |
| 11 | Sheila Mercado | Endocrinology | Manati, PR | 183 | $109K |
| 12 | Lorenzo Ross Rivera | General Practice | Guayama, PR | 163 | $109K |
| 13 | Manuel Alegre-Hernandez | Endocrinology | San Juan, PR | 109 | $108K |
| 14 | Joo Jang | Nurse Practitioner | Leonia, NJ | 132 | $104K |
| 15 | Razmik Ohanjanian | Internal Medicine | Glendale, CA | 165 | $103K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 385 | Fremanezumab-Vfrm (Ajovy Autoinjector) | $24.7M | 29,389 |
| 386 | Nitrofurantoin Monohyd/M-Cryst (Nitrofurantoin Mono-Macro) | $24.4M | 1,173,249 |
| 387 | Pegfilgrastim (Neulasta) | $24.4M | 3,096 |
| 388 | Linagliptin/Metformin Hcl (Jentadueto) | $24.3M | 33,018 |
| 389 | Ocrelizumab (Ocrevus) | $24.2M | 639 |
| 390 | Fenofibrate (Fenofibrate) | $24.2M | 670,936 |
| 391 | Empaglifloz/Linaglip/Metformin (Trijardy Xr) | $23.9M | 28,001 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology